Home / FAM222B Knockout Cell Lines

FAM222B Knockout Cell Lines

Gene: FAM222B

Official Full Name: family with sequence similarity 222 member Bprovided by HGNC

Gene Summary: Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO17735 FAM222B Knockout cell line (HeLa) Human FAM222B 1:3~1:6 Negative Online Inquiry
KO17736 FAM222B Knockout cell line (HCT 116) Human FAM222B 1:2~1:4 Negative Online Inquiry
KO17737 FAM222B Knockout cell line (HEK293) Human FAM222B 1:3~1:6 Negative Online Inquiry
KO17738 FAM222B Knockout cell line (A549) Human FAM222B 1:3~1:4 Negative Online Inquiry

Background

FAM222B Gene Knockout Cell Lines are specialized cellular models engineered to exhibit complete loss of function for the FAM222B gene, which is implicated in various cellular processes including proliferation, differentiation, and apoptosis. This product serves as a critical tool for researchers focusing on gene function studies, disease modeling, and therapeutic target validation. By utilizing the CRISPR/Cas9 gene-editing technology, these cell lines facilitate precise and efficient knockouts, enabling the elucidation of FAM222B's role in biological systems.

Key functions of FAM222B gene knockout involve the investigation of intracellular signaling pathways and genomic stability, as research has indicated its potential role in cancer progression and cellular response to stress. The mechanism behind these knockout cell lines lies in their ability to mimic disease states by allowing scientists to observe phenotypic changes and molecular interactions that result from the absence of the FAM222B protein. This can be invaluable in experimental frameworks where understanding the biological implications of gene loss is crucial.

The scientific importance of FAM222B Gene Knockout Cell Lines spans both research and clinical applications. In research settings, these cell lines empower scientists to perform high-throughput screening, functional assays, and gene interaction studies, providing insights into cellular mechanisms that contribute to malignancies and other health conditions. Clinically, they are pivotal in advancing personalized medicine initiatives by identifying how variations in gene expression affect treatment efficacy.

Compared to alternative gene knockout models, FAM222B Gene Knockout Cell Lines stand out due to their high specificity, efficiency, and reproducibility. While traditional methods may produce off-target effects, our CRISPR-mediated approach ensures accurate gene disruption, which enhances the reliability of experimental outcomes. Moreover, these cell lines can be readily adapted to various assays, offering significant flexibility to researchers.

For investigators and clinicians alike, the FAM222B Gene Knockout Cell Lines represent a valuable asset in the quest for deeper understanding of genetic contributions to health and disease. Their ability to provide reliable and reproducible data makes them indispensable tools in both academic and industrial laboratories.

Our company specializes in high-quality, innovative biological products, and we are committed to supporting the scientific community with advanced tools that facilitate cutting-edge research and drive clinical advancements. With expertise in gene editing technologies and cellular models, we continuously strive to enhance research outcomes for our customers.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.